Medical News Interviews
Franz Messerli
New York cardiologist Franz Messerli explains to Peter Goodwin why he doesn’t prescribe the popular diuretic hydrochlorothiazide as initial therapy for hypertension any more, as he announced in a “Late-Breaker” session at the European Meeting on Hypertension in Milan.
LISTEN
[audio:https://www.audiomedica.com/podcasting/cardio/090614FranzMesserliPODCAST.mp3]
Rosuvastatin: No Significant Benefit for Older Patients with Systolic Heart Failure: CORONA Study Results 6 Nov, 2007 Bioabsorbable Everolimus-Eluting Stent: 6-Month Angiographic and IVUS Results 26 Mar, 2007 
Competitive and Leisure Sports: Recommendations to Minimise Cardiovascular Risk 28 Aug, 2016 Better Criteria For Cardiac Resynchronisation Needed in Heart Failure: PROSPECT Trial Results 5 Sep, 2007 
COVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
